| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in SNSE over the last quarter tilts toward selling: insiders offloaded a net 34,359 shares worth roughly $600K.
Classified under Biotechnology (Health Care sector), SNSE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | - | - | |
| Pres | 220.0K | - | - | |
| 10% | 130.6K | $2.61M | - | |
| 10% | 130.6K | $2.61M | - | |
| Other | 80.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 1,000 | $14.00 | $14,000.00 | - | -32.3% | -84.4% | |
| Mar 30, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 2,000 | $12.00 | $24,000.00 | - | -12.0% | -81.1% | |
| Mar 30, 2021 | Peyer James | Director, 10% Owner | Buy | 2,000 | $12.00 | $24,000.00 | - | -12.0% | -81.1% | |
| Mar 24, 2021 | Peyer James | Director, 10% Owner | Buy | 3,750 | $14.12 | $52,950.00 | - | -17.6% | -81.1% | |
| Mar 24, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 3,750 | $14.12 | $52,950.00 | - | -17.6% | -81.1% | |
| Mar 23, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 10,000 | $14.34 | $143,400.00 | +0.2% | -21.1% | -82.6% | |
| Mar 23, 2021 | Peyer James | Director, 10% Owner | Buy | 10,000 | $14.34 | $143,400.00 | +0.2% | -21.1% | -82.6% | |
| Mar 22, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 2,183 | $15.02 | $32,788.66 | - | -25.9% | -82.2% | |
| Mar 22, 2021 | Peyer James | Director, 10% Owner | Buy | 2,183 | $15.02 | $32,788.66 | - | -25.9% | -82.2% | |
| Mar 18, 2021 | Cambrian Biopharma Inc | 10% Owner | Buy | 817 | $15.25 | $12,459.25 | - | -18.1% | -81.9% |